Filter by:

  • Ann Ager is chair of its Forum and a trustee for the British Society for Immunology, and council member of the International Union of Immunological Societies. She discusses her role as an advocate for immunology to governments and other policy makers.

    • Ann Ager
  • Progress in understanding the rare disease Langerhans cell histiocytosis has stimulated immersive meetings occurring annually over a 30-year period that bring together clinicians, scientists and patients in a unique collaboration.

    • Carl E. Allen
    • Peter C. L. Beverley
    • Astrid van Halteren
  • With record levels of vaccine hesitancy and one of the most drastic reinforcements of vaccine mandates in recent years, there is much to learn from the French experience.

    • Jeremy K. Ward
    • Patrick Peretti-Watel
    • Pierre Verger
  • Mice are generally the ‘go-to’ organism for modeling of the human immune system, but this often leads to inaccurate interpretations. Ernst and Carvunis argue in this Comment that taking into account the evolutionary and environmental context can generate better models of disease.

    • Peter B. Ernst
    • Anne-Ruxandra Carvunis
  • Netea and colleagues provide a general guide to the cellular and humoral contributors to inflammation as well as the pathways that characterize inflammation in specific organs and tissues.

    • Mihai G Netea
    • Frances Balkwill
    • Charles A Dinarello
  • Omissions of qualified women scientists from major meeting programs continue to occur despite a surge in articles indicating persistent gender-discriminatory practices in hiring and promotion, and calls for gender balance in conference organizing committees.

    • Robyn S Klein
    • Rhonda Voskuhl
    • Anne H Cross
  • Mass cytometry is shaping up to be a transformative technology for the description of immunological cell populations. In their Commentary, however, Newell and Cheng report that with great power comes great complexity and concomitant challenges for data analysis and visualization.

    • Evan W Newell
    • Yang Cheng
  • Targeting innate lymphoid cells, the innate counterparts of T cells, might help direct an appropriate immune response during preventive and therapeutic strategies aimed at pathogens and inflammatory pathologies

    • Sascha Cording
    • Jasna Medvedovic
    • Gérard Eberl